PathAI Overview

  • Founded

  • 2016

Founded
  • Status

  • Private

  • Employees

  • 363

Employees
  • Latest Deal Type

  • Mezzanine

  • Latest Deal Amount

  • $28.5M

  • Investors

  • 23

PathAI General Information

Description

Developer of an artificial intelligence-powered research platform intended to improve the accuracy and efficiency of cancer diagnosis and treatment. The company's platform applies machine and deep learning techniques to massive aggregated sets in order to detect cancerous cells separately, enabling pathologists to diagnose cancer patients rapidly and accurately.

Contact Information

Website
www.pathai.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Primary Office
  • 1325 Boylston Street
  • Suite 10000
  • Boston, MA 02215
  • United States
+1 (617) 000-0000

PathAI Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PathAI Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Mezzanine 23-Dec-2022 $28.5M 00000 Completed Generating Revenue
6. Debt - General 01-Jan-2022 00000 00000 Completed Generating Revenue
5. Later Stage VC (Series C) 18-May-2021 00000 00000 00.000 Completed Generating Revenue
4. Later Stage VC 01-Jan-2021 0000 Completed Generating Revenue
3. Early Stage VC (Series B) 04-Nov-2019 0000 0000 00000 Completed Generating Revenue
2. Early Stage VC 23-Jul-2019 $15M Completed Generating Revenue
1. Early Stage VC (Series A) 31-Oct-2017 $15M $15M 0000 Completed Startup
To view PathAI’s complete valuation and funding history, request access »

PathAI Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C 0,000,000 00.000000 00 000.0 000.0 00 000.0 00.000
Series B 0,000,000 00.000000 00 000.00 000.00 00 000.00 00.000
Series A4 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A3 00,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A2 00,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A1 2,168,963 $0.000100 6% $1.76 $1.76 1x $1.76 6.3%
Series A 3,449,295 $0.000100 6% $3.25 $3.25 1x $3.25 10.03%
To view PathAI’s complete cap table history, request access »

PathAI Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an artificial intelligence-powered research platform intended to improve the accuracy and efficiency of can
Discovery Tools (Healthcare)
Boston, MA
363 As of 2023
00000
000000000000 00000

0000 0

consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolo
0000000000000 000000
Paris, France
00 As of 0000
0000
0.00 0000-00-00
0000000000 0 0000

00000

citation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irur
0000000000000
Irving, TX
0000 As of 0000
00.00
000000000 00 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PathAI Competitors (19)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Keen Eye Venture Capital-Backed Paris, France 00 0000 0000000000 0 0000
00000 0000 0000000 Private Equity-Backed Irving, TX 0000 00.00 000000000 00 00.00
0000000 Private Equity-Backed Philadelphia, PA 000 000.00 0000000 0000 000.00
000000000 Pending Transaction (M&A) Tampa, FL 000000&0
0000000 0000000 00 Venture Capital-Backed London, United Kingdom 00 000.00 0000000000 0 000.00
You’re viewing 5 of 19 competitors. Get the full list »

PathAI Patents

  • 10

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 4

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

PathAI Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220375606-A1 Systems and methods for machine learning (ml) model diagnostic assessments based on digital pathology data Pending 18-May-2021 0000000000
US-20220245802-A1 Systems and methods for classifying biomedical image data using a graph neural network Pending 01-Feb-2021 0000000000
US-11536655-B1 Imaging systems with angled sensors and related methods Active 18-Feb-2020 00000000000 00
US-11527319-B1 Systems and methods for frame-based validation Active 13-Sep-2019 000000000 0
US-11657505-B1 Systems and methods for training a model to predict survival time for a patient Active 06-Jun-2017 G06T7/0014 00
To view PathAI’s complete patent history, request access »

PathAI Executive Team (16)

Name Title Board Seat Contact Info
Andrew Beck Ph.D Co-Founder, Chief Executive Officer, President & Board Member
Brandon Eldredge Chief Financial Officer
Tiffany Freitas Chief Operating Officer & Chief Business Officer
Christian Krautkramer Chief Compliance Officer & Associate General Counsel
Elizabeth Storti Chief People Officer
You’re viewing 5 of 16 executive team members. Get the full list »

PathAI Board Members (11)

Name Representing Role Since
Andrew Beck Ph.D PathAI Co-Founder, Chief Executive Officer, President & Board Member 000 0000
Jeffrey Leiden Ph.D Self Chairman 000 0000
Robert Perez General Atlantic Board Member 000 0000
Stanley Lapidus Self Board Member 000 0000
You’re viewing 4 of 11 board members. Get the full list »

PathAI Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PathAI Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hercules Capital BDC Lender/Debt Provider Minority 000 0000 000000 0
Ad Super Corporation Minority 000 0000 000000 0
Biospring Partners Growth/Expansion Minority 000 0000 000000 0
D1 Capital Partners Hedge Fund Minority 000 0000 000000 0
Kaiser Permanente Corporation Minority 000 0000 000000 0
You’re viewing 5 of 23 investors. Get the full list »

PathAI Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 26-Jul-2021 0000000000 Laboratory Services (Healthcare) 000000 00
To view PathAI’s complete acquisitions history, request access »

Ready to get started?

Request a free trial